Enfusion Stock Price, News & Analysis

Enfusion, Inc. (NYSE: ENFN) is a software company focused on the financial services industry. According to available information, Enfusion provides software-as-a-service (SaaS) solutions designed for investment managers, hedge funds, and asset managers. The company is associated with the software publishers industry within the information sector.

Enfusion is described as an investment management SaaS platform that removes traditional information boundaries by uniting front-, middle-, and back-office teams on one system. Through its software, analytics, and middle/back-office managed services, Enfusion aims to support real-time, data-driven workflows and collaboration for institutional investors. Its platform is cited as providing real-time portfolio and order management, IBOR, risk analytics, and reporting in one system, with an emphasis on eliminating batch processing, manual reconciliation, and data duplication.

Available descriptions note that Enfusion partners with hundreds of investment managers and operates from multiple global offices across several continents. The company has been referenced as serving hedge funds and asset managers and as working with investment managers across different strategies and asset classes. Its solutions are positioned as a technology foundation for modern investment operations, with a focus on front-office capabilities integrated with operational and reporting functions.

In a corporate development, Enfusion is identified in news reports as “a Clearwater Analytics company” and as being acquired by Clearwater Analytics Holdings, Inc. (NYSE: CWAN) in a transaction valued at approximately $1.5 billion. A press release dated April 21, 2025, states that Clearwater completed its acquisition of Enfusion, and that Enfusion’s technology is being combined with Clearwater’s middle- and back-office platform to form a unified, cloud-native front-to-back investment management offering. Historical news also details the merger agreement announced on January 13, 2025, under which Clearwater agreed to acquire Enfusion for a mix of cash and stock.

Prior to the acquisition, Enfusion reported financial results as an independent public company. For example, Enfusion announced financial results for the fourth quarter and full year ended December 31, 2024, including revenues, margins, and other metrics. These disclosures characterize Enfusion as a recurring-revenue SaaS business serving investment managers, with platform subscriptions and managed services as key revenue categories. The company also tracks metrics such as Annual Recurring Revenue (ARR), Average Contract Value (ACV), and Net Dollar Retention Rate as indicators of its business performance.

Earlier descriptions from market data sources further characterize Enfusion as a cloud-based portfolio management and risk system provider. It has been described as headquartered in Chicago, Illinois, with a branch office in New York, New York, and wholly owned subsidiaries in London and Hong Kong. Clients are described as relying on real-time performance, risk calculations, and accounting for sophisticated financial products, and the company has been noted as serving hedge funds with substantial assets under management. These details provide historical context on Enfusion’s geographic footprint and client base.

Following the completion of the Clearwater transaction, Enfusion’s ticker symbol ENFN represents the historical listing of the company as a standalone issuer. Current references in news releases describe Enfusion as operating within Clearwater as part of a broader front-to-back investment management platform. Investors researching ENFN can use this page to understand the company’s historical role as a SaaS provider to investment managers and its subsequent integration into Clearwater’s business.

Business Focus

Based on company and transaction disclosures, Enfusion’s core focus includes:

• Investment management SaaS platform that unites front-, middle-, and back-office teams on one system.
• Front-office technology foundation for hedge funds and asset managers, including portfolio and order management and IBOR.
• Risk analytics and reporting delivered in real time to support operational workflows and portfolio oversight.
• Middle/back-office managed services associated with its software platform.

Corporate Status and Relationship with Clearwater Analytics

News releases state that Clearwater Analytics and Enfusion entered into a definitive merger agreement for Clearwater to acquire Enfusion, with the transaction anticipated to close in the second quarter of 2025. A later release dated April 21, 2025, reports the successful completion of Clearwater’s acquisition of Enfusion in a deal valued at approximately $1.5 billion and refers to Enfusion as “a Clearwater Analytics company.” These statements indicate that Enfusion transitioned from an independent public company to part of Clearwater’s consolidated operations.

For users examining ENFN as a historical ticker, this context is important: ENFN relates to Enfusion’s period as a separately listed entity on the New York Stock Exchange prior to and through its acquisition by Clearwater. Subsequent operations and branding are described in public communications as part of Clearwater’s platform.